Biotech | May 06, 2022
ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
TSCS appeals to the Govt. of Telangana to release a G.O for mandatory antenatal test - HbA2 for every pregnant woman to help prevent the birth of Thalassemia Major Children for the well-being of their family & Telangana State
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Under the terms of the agreement, Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Subscribe To Our Newsletter & Stay Updated
